Seven new agents have received FDA approval since October 2022.
Glenn Roma, PharmD, PhD BCOP
Advertisement
Articles by Glenn Roma, PharmD, PhD BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
4
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
5
